NFlection Therapeutics Announces Orphan Drug Designation of NFX-179 for the Treatment of Cutaneous Neurofibromatosis Type 1 August 18, 2021
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer August 18, 2021
Flywire Survey: Majority of Americans Want Consumer-Friendly Ways to Pay for Healthcare August 17, 2021
Branch Insurance Partners with Snapsheet Claims Platform to Accelerate the Claims Experience August 17, 2021
As US review of Eli Lilly-partnered PD-1 gets underway, Innovent touts another frontline win in China August 16, 2021
Avidity Biosciences Enters Into Collaboration with FSHD Clinical Trial Network to Support Development of Biomarkers for Future Clinical Trial Use August 16, 2021
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma August 15, 2021
Innovusion Raises $66 Million in Series B Plus Financing to Accelerate the Global Adoption of Autonomous Transportation August 13, 2021